Rhodomyrtone decreases expression of inflammatory transcripts by TNF-α+IL-17A stimulated in skin organ cultures. by Julalak Chorachoo (5855852)

“…<p>Skin biopsies were pre-treated with 400 ng/ml rhodomyrtone 6 h before stimulation with 10 ng/ml TNF-α and 20 ng/ml IL-17A. Rhodomyrtone treatment decreases production of <i>DEFB4</i>, <i>IL1B</i>, <i>IL17C</i>, <i>IL36G</i>, <i>LCN2</i>, <i>PI3</i>, <i>S100A7</i>, and <i>S100A8</i> transcripts as measured by qRT-PCR at 72 h. …”

Twist1 and Snail1 protein levels after 100 μM RSV administration for 96 hs. by Chiara Cilibrasi (3636838)

Cytoplasmic and nuclear β catenin protein levels after 100 μM RSV administration for 96 hs. by Chiara Cilibrasi (3636838)

Adding tsetse control to medical activities contributes to decreasing transmission of sleeping sickness in the Mandoul focus (Chad) by Mahamat Hissene Mahamat (4282306)

“…In the South of Chad, the Mandoul area is a persistent focus of Gambian sleeping sickness where around 100 HAT cases were still diagnosed and treated annually until 2013. …”

JNK inhibitor AS601245 decreased levels of Bim and CC3 proteins and reduced neuronal apoptosis and brain infarct volume in P7 rat after HI. by Deyuan Li (769599)

“…The infarct volume in the AS601245-treated brain was decreased by 58% compared with the DMSO controls (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0132998#pone.0132998.g004" target="_blank">Fig 4I</a>).…”

Changes in mortality and DALYs per100,000 rates by cancer types from 1990 to 2019 in Iran; a) Mortality rate; b) DALYs per100000 rate. by Mitra Darbandi (17967619)

Expression of LMW tropomyosin in Type 2 diabetes. by Stuart A. Savill (3129060)

Tropomyosin isoform expression in normal controls and patients with Type 2 diabetes. by Stuart A. Savill (3129060)

Primer Sequences. by Stuart A. Savill (3129060)

Expression of HMW tropomyosin in Type 2 diabetes. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to TNFα. by Stuart A. Savill (3129060)

TPM1 protein expression in response to inflammatory cytokines. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to IL-1α. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to TNFα. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to glucose and insulin. by Stuart A. Savill (3129060)

TPM1 and TPM4 expression in response to IL-1α. by Stuart A. Savill (3129060)

Repeat sampling of individuals with Type 2 diabetes. by Stuart A. Savill (3129060)

Localized schematic of ball valves with different openings (a) 25%; (b) 50%; (c) 75%; (d) 100%. by Weiqing Xu (1279959)

Distribution of hydrogen volume fraction at different openings (a) 25%; (b) 50%; (c) 75%; (d) 100%. by Weiqing Xu (1279959)

Genes whose expression was decreased by 1 mM ouabain by more than 2-fold. by Larisa V. Smolyaninova (3600053)